Disclosure The authors have declared that they have no interests which might be perceived as posing a conflict or a bias.
Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial
Article first published online: 17 APR 2008
© 2008 The Authors. Journal compilation © 2008 Blackwell Publishing Ltd
International Journal of Clinical Practice
Volume 62, Issue 6, pages 919–924, June 2008
How to Cite
Anastasilakis, A. D., Goulis, D. G., Polyzos, S. A., Gerou, S., Koukoulis, G. N., Efstathiadou, Z., Kita, M. and Avramidis, A. (2008), Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial. International Journal of Clinical Practice, 62: 919–924. doi: 10.1111/j.1742-1241.2008.01768.x
- Issue published online: 17 APR 2008
- Article first published online: 17 APR 2008
- Paper received December 2007, accepted March 2008
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.